InflaRx completes enrollment in mid-stage vilobelimab skin disease trial
April 15 2021 - 7:46AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Sep 2023 to Sep 2024